李拂晓，主要从事肿瘤预防相关研究，涉及一级预防（肿瘤的危险因素探索）、二级预防（肿瘤高风险人群的早诊早治）及三级预防（肿瘤临床治疗的不良反应及其预防如肿瘤心脏病学）。研究经历既包括人群现场干预性工作如河南食管癌高发区肿瘤筛查随机对照试验，也包括基于医学大数据的观察性研究如前瞻性人群队列UKBiobank和回顾性的电子病历数据库。研究兴趣包括疾病风险预测、卫生经济学评价、系统综述与meta分析等。
学习经历：
(1) 2016-08 至 2021-07, 北京大学, 肿瘤学, 博士 （导师：柯杨）
(2) 2013-08 至 2016-07, 北京大学, 经济学, 学士
(3) 2011-08 至 2016-07, 北京大学, 预防医学, 学士
工作经历：
2021-07至2024-06，博士后（导师：唐金陵）
北京大学优秀毕业生2016年
主持中国博士后科学基金一项《中国食管癌高发区精准筛查策略的构建及其卫生经济学评价》2023-02至2024-12
研究论文Efficacy of SARS-CoV-2 vaccines and the dose-response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials获评深圳市第三届优秀科技学术论文成果
Li FX, Zhao HY, Lin TF, Jiang YW, Liu D, Wei C, et al.Regular Glucosamine Use May Have Different Roles in the Risk of Site-Specific Cancers: Findings from a Large Prospective Cohort. Cancer Epidem Biomar 2023, 32(4): 531-541.
Li FX, Liu MF, Guo CH, Xu RP, Li FL, Liu Z, et al.Cost-effectiveness of precision screening for esophageal cancer based on individualized risk stratification in China: Real-world evidence from the ESECC trial. Front Oncol 2022, 12.
Li FX, Hu YJ, Guo CH, Lei L, Li FL, Liu MF, et al.Economic Burden Conferred by Population-Level Cancer Screening on Resource-Limited Communities: Lessons From the ESECC Trial. Front Oncol 2022, 12.
Li F, Li X, Guo C, Xu R, Li F, Pan Y, et al.Estimation of Cost for Endoscopic Screening for Esophageal Cancer in a High-Risk Population in Rural China: Results from a Population-Level Randomized Controlled Trial. Pharmacoeconomics 2019, 37(6): 819-827.
Li FX, Wei C, Li BL, Lin TF, Jiang YW, Liu D, et al.Characteristics and Containment of 74 Imported COVID-19 Outbreaks: Experiences, Lessons, and Implications - China, 2020-2021. China Cdc Weekly 2022, 4(50): 1131-+.
Yang ZR, Jiang YW,Li FX, Liu D, Lin TF, Zhao ZY, et al.Efficacy of SARS-CoV-2 vaccines and the dose-response relationship with three major antibodies: a systematic review and meta-analysis of randomised controlled trials.Lancet Microbe2023, 4(4): E236-E246.
Lin TF, Zhao ZY, Yuan CZ, Huang YH, Liu D,Li FX,et al. Life satisfaction components and all-cause and cause-specific mortality: a large prospective cohort study.Journal of Affective Disorders,2024.
Jia YX, Li BL, Yang ZR,Li FX, Zhao ZY, Wei C, et al.Trends of Randomized Clinical Trials Citing Prior Systematic Reviews, 2007-2021.Jama Netw Open2023, 6(3).
Lin TF, Zhao ZY, Yang ZR, Li BL, Wei C,Li FX, et al.Hospital Strain and COVID-19 Fatality - England, April 2020-March 2022.China Cdc Weekly2022, 4(52): 1176-+.
Liu D, Jiang YW, Wang SY,Li FX, Lin TF, Li BL,et al. Relative effectiveness and durability of the first and second booster doses of SARS-CoV-2 vaccines: a systematic review and meta-analysis.The Innovation Medicine,2024
